Dec 3, 2015, 07:28 AM by Michael Croft

LONDON, UNITED KINGDOM - Dec 4, 2015 - Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually Digital Surgical Simulator Touch Surgery collaborates with Experts Surgeons at International Institutions (Stanford, Harvard Yale, Dartmouth, Vanderbilt, Imperial College London,& Others) to Create Surgical Simulations

Dec 1, 2015, 14:54 PM by Michael Croft

Computerworld | Hewlett Packard Enterprise outlined new details about its hybrid cloud partnership with Microsoft in an announcement Tuesday, saying it will provide a new hardware product that integrates with the Azure cloud platform and build its software to take advantage of Microsoft's offerings.

Dec 1, 2015, 12:01 PM by Michael Croft

ST. LOUIS, MO, UNITED STATES - Dec 1, 2015 - A long-term project aimed at improving photosynthesis in rice is entering its third stage, marking another step on the road to significantly increased crop yields that will help meet the food needs of billions of people across the developing world

Dec 1, 2015, 10:58 AM by Michael Croft

PRINCETON, NJ - Dec 1, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that it has acquired XenologiQ, a UK-based quantitative systems pharmacology (QSP) consultancy

Nov 30, 2015, 15:45 PM by Michael Croft

Bio-IT World | Human Longevity this morning announced that it has acquired Cypher Genomics for an undisclosed amount. Cypher has 14 employees who will join HLI including Cypher CEO and Co-founder, Ashley Van Zeeland, Ph.D., who is now the head of HLI's Pediatric Business.

Nov 30, 2015, 15:34 PM by Michael Croft

Wired | uBiome has announced a partnership with the Centers for Disease Control and Prevention to develop a standardized way of measuring disruptions and changes to the human microbiome.

Nov 30, 2015, 10:58 AM by Michael Croft

The Atlantic | CRISPR-Cas9 experiments are revealing which human genes are essential, and which matter specifically to cancer cells.

Nov 30, 2015, 03:31 AM by Michael Croft

ULSAN, SOUTH KOREA - Nov 24, 2015 - Alzheimer's disease (AD) is one of the most well-known and common form of dementia. It is also a progressive, degenerative brain disease whose cause is not fully understood, however, amyloid-β (Aβ) peptides, metal ions and reactive oxygen species (ROS) have been suggested to be involved in AD pathogenesis

Nov 26, 2015, 09:30 AM by Michael Croft

BOSTON, MA - Nov 26, 2015 - The creators behind sciNote - an open source electronic laboratory notebook (ELN) - believe that laboratories deserve reliable and easy-to-use software at affordable prices

Nov 25, 2015, 11:40 AM by Michael Croft

Diagnostics World | Quanterix, the Lexington, Mass.-based creator of a high-throughput protein analysis instrument, is overhauling its hardware and software as it prepares for a more commercial stage in its development.

Nov 24, 2015, 10:40 AM by Michael Croft

Bio-IT World News Brief | Complete Genomics of Mountain View, Calif., is undergoing a big shakeup under the direction of its Shenzhen-based owner BGI, reorganizing as a research site developing assays for the BGISEQ-500 and cutting short the launch of its Revolocity clinical sequencing system.

Nov 24, 2015, 08:21 AM by Michael Croft

ULSAN, KOREA - Nov 25, 2015 -  The Ulsan 10,000 Genome Project, entitled the "Genome Korea in Ulsan" has been launched in Ulsan Metropolitan City on the 25th of Nov

Nov 23, 2015, 15:53 PM by Michael Croft

STAT | Scientists have used the CRISPR-Cas9 genome-editing tool to create mosquitoes that block the malaria parasite instead of transmitting it - and rapidly spread their modified DNA to nearly all their descendants.

Nov 20, 2015, 13:15 PM by Michael Croft

Bio-IT World | Thermo Fisher Scientific announced this week that it will be creating a next-generation sequencing test as a companion diagnostic in cases of non-small cell lung cancer, partnering with Novartis and Pfizer.

Nov 20, 2015, 09:24 AM by Michael Croft

BASEL, N/A, SWITZERLAND - Nov 20, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced it has signed a five-year license agreement with AstraZeneca

Nov 19, 2015, 10:55 AM by Michael Croft

Bio-IT World | Oxford Nanopore, creator of the handheld MinION DNA sequencer, recently revealed its first user-facing tool for genetic interpretation, a species identification workflow called What's in my Pot? The tool, designed by Oxford's software spinout Metrichor, hints at the company's ambitions to bring DNA analysis to a much wider audience, as the MinION broadens notions of who can perform sequencing and where.

Nov 19, 2015, 09:17 AM by Michael Croft

Nature News | The idea of two sexes, divided neatly by X and Y chromosomes, is simplistic. Biologists are now finding a fascinating number and variety of ways genetics can defy the binary.

Nov 19, 2015, 05:39 AM by Michael Croft

NOTTINGHAM, UNITED KINGDOM - Nov 19, 2015 - Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage capsule filling expertise with the expansion of its Xcelodose® powder micro-dosing system as part of its suite of GMP capabiliThe move by the contract development and manufacturing organisation (CDMO) follows demand from its clients to develop the technique to complement its development services and help get new molecules to Phase I clinical trials quicker

Nov 18, 2015, 11:39 AM by Michael Croft

- Nov 18, 2015 - Cogstate Ltd (ASX: CGS), leaders in the measurement of cognition in clinical trials, is pleased to announce that their iPad-based computerized cognitive assessment technology has been selected for use in a multicenter Phase IV observational study to assess the tolerability of two approved drugs for the treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Nov 18, 2015, 10:05 AM by Michael Croft

Bio-IT World | Deep Genomics this morning announced the closing of $3.7 million in seed financing. Funding was led by True Ventures of the Bay Area with participation from Bloomberg Beta and other global angel investors.